Intraaortic balloon support for myocardial infarction with cardiogenic shock

New England Journal of Medicine

Volumn 367, Issue 14, 2012, Pages 1287-1296

  Thiele, Holger ^a   Zeymer, Uwe ^b   Neumann, Franz Josef ^c   Ferenc, Miroslaw ^c   Olbrich, Hans Georg ^d   Hausleiter, Jörg ^e   Richardt, Gert ^f   Hennersdorf, Marcus ^g   Empen, Klaus ^h   Fuernau, Georg ^a   Desch, Steffen ^a   Eitel, Ingo ^a   Hambrecht, Rainer ⁱ   Fuhrmann, Jörg ^j   Böhm, Michael ^k   Ebelt, Henning ^l   Schneider, Steffen ^b   Schuler, Gerhard ^a   Werdan, Karl ^l  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b KLINIKUM LUDWIGSHAFEN   (Germany)

^c UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^d Asklepios Clinic Langen Seligenstadt   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f Heart Center Segeberger Kliniken   (Germany)

^g SLK Kliniken Heilbronn   (Germany)

^h UNIVERSITY OF GREIFSWALD   (Germany)

ⁱ Klinikum Links der Weser   (Germany)

^j ZENTRALKLINIK BAD BERKA   (Germany)

^k SAARLAND UNIVERSITY   (Germany)

^l MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CATECHOLAMINE; LACTIC ACID;

ACUTE HEART INFARCTION; ADULT; AGED; ANTERIOR MYOCARDIAL INFARCTION; ARTICLE; BLEEDING; CARDIOGENIC SHOCK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; COUNTERPULSATION; DISEASE SEVERITY; FEMALE; HUMAN; INTENSIVE CARE; INTRAAORTIC BALLOON COUNTERPULSATION; INTRAAORTIC BALLOON PUMP; KIDNEY FUNCTION; LACTATE BLOOD LEVEL; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OPEN STUDY; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL ISCHEMIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SCORING SYSTEM; SEPSIS; SIMPLIFIED ACUTE PHYSIOLOGY SCORE II; SURVIVAL RATE; VENTRICULAR ASSIST DEVICE;

EID: 84866733177     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1208410     Document Type: Article

References (28)

1. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999;341:625-34.
2. Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2005;294:448-54.
3. Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation 2009;119:1211-9.
4. Jeger RV, Radovanovic D, Hunziker PR, et al. Ten-year incidence and treatment of cardiogenic shock. Ann Intern Med 2008;149:618-26.
5. Thiele H, Allam B, Chatellier G, Schuler G, Lafont A. Shock in acute myocardial infarction: the Cape Horn for trials? Eur Heart J 2010;31:1828-35.
6. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004;110:588-636. [Erratum, Circulation 2005;111:2013.]
7. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008;29:2909-45.
8. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. Eur Heart J 2010;31:2501-55.
9. Sjauw KD, Engström AE, Vis MM, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 2009;30:459-68.
10. Prondzinsky R, Lemm H, Swyter M, et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 2010;38:152-60.
11. Thiele H, Schuler G, Neumann F-J, et al. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J 2012;163:938-45.
12. Werdan K, Ruß M, Buerke M, Delle-Karth G, Geppert A, Schöndube FA. Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment - a German-Austrian S3 Guideline. Dtsch Arztebl Int 2012;109:343-51.
13. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
14. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-63. [Erratum, JAMA 1994;271:1321.]
15. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
16. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 2003;107:2998-3002.
17. Scheidt S, Wilner G, Mueller H, et al. Intra-aortic balloon counterpulsation in cardiogenic shock - report of a cooperative clinical trial. N Engl J Med 1973;288:979-84.
18. Prondzinsky R, Unverzagt S, Russ M, et al. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial. Shock 2012;37:378-84.
19. Abdel-Wahab M, Saad M, Kynast J, et al. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 2010;105:967-71.
20. Patel MR, Smalling RW, Thiele H, et al. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA 2011;306:1329-37.
21. Cheng JM, den Uil CA, Hoeks SE, et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J 2009;30:2102-8.
22. Wilson SR, Mudge GH Jr, Stewart GC, Givertz MM. Evaluation for a ventricular assist device: selecting the appropriate candidate. Circulation 2009;119:2225-32.
23. Unverzagt S, Machemer MT, Solms A, et al. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev 2011;7:CD007398.
24. Thiele H, Lauer B, Hambrecht R, Boudriot E, Cohen HA, Schuler G. Reversal of cardiogenic shock by percutaneous left-atrial-to-femoral arterial bypass assistance. Circulation 2001;104:2917-22.
25. Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support versus a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005;26:1276-83.
26. Fincke R, Hochman JS, Lowe AM, et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol 2004;44:340-8.
27. Prondzinsky R, Unverzagt S, Lemm H, et al. Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock. Clin Res Cardiol 2012;101:375-84.
28. The TRIUMPH Investigators. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA 2007;297:1657-66.